Fairmount Funds Management »

Axsome Therapeutics shares owned by Fairmount Funds Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Fairmount Funds Management from 13F filings

Historical chart of Fairmount Funds Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Fairmount Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Fairmount Funds Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $188M 2.4M 79.59
2023-09-30 $164M 2.3M 69.89
2023-06-30 $169M 2.3M 71.86
2023-03-31 $124M 2.0M 61.68
2022-12-31 $155M 2.0M 77.13
2022-09-30 $85M 1.9M 44.62
2022-06-30 $36M 943k 38.30
2022-03-31 $39M 943k 41.39
2021-12-31 $7.1M 188k 37.78
2021-09-30 $6.2M 188k 32.96
2021-06-30 $21M 313k 67.46
2021-03-31 $14M 252k 56.62
2020-12-31 $18M 220k 81.47
2020-09-30 $16M 220k 71.25
2020-06-30 $18M 216k 82.28
2020-03-31 $11M 190k 58.83